ATI RN
ATI Mental Health Proctored Exam 2023
1. Which statement made by a patient prescribed bupropion (Wellbutrin) demonstrates that the medication education the patient received was effective?
- A. I hope Wellbutrin will help my depression and also help me to finally quit smoking.
- B. I'm happy to hear that I won't need to worry too much about weight gain.
- C. It's okay to take Wellbutrin since I haven't had a seizure in 6 months.
- D. I need to be careful about driving since the medication could make me drowsy.
Correct answer: A
Rationale: Choice A is the correct answer because it shows that the patient understands the dual benefits of bupropion (Wellbutrin) in treating depression and aiding in smoking cessation. Bupropion is commonly prescribed for these reasons as it has a lower risk of weight gain compared to other antidepressants. Choices B, C, and D are not the most appropriate because they do not specifically reflect the benefits or key information related to bupropion therapy.
2. When a patient with major depressive disorder is prescribed escitalopram, what potential side effect should the healthcare provider educate the patient about?
- A. Weight gain
- B. Insomnia
- C. Diarrhea
- D. Hypertension
Correct answer: B
Rationale: The correct answer is B: Insomnia. Escitalopram, a selective serotonin reuptake inhibitor (SSRI), commonly causes insomnia as a side effect. Patients should be informed about the possibility of experiencing difficulty falling or staying asleep when starting this medication. Choices A, C, and D are incorrect because weight gain, diarrhea, and hypertension are not typically associated with escitalopram use.
3. How do psychiatrists determine which diagnosis to give a patient?
- A. Psychiatrists use pre-established criteria from the APA's Diagnostic and Statistical Manual of Mental Disorders (DSM-5).
- B. Hospital policy dictates how psychiatrists diagnose mental disorders.
- C. Psychiatrists assess the patient and identify diagnoses based on the patient's unhealthy responses and contributing factors.
- D. The American Medical Association identifies 10 diagnostic labels that psychiatrists can choose from.
Correct answer: A
Rationale: The correct answer is A. Psychiatrists use the criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) published by the American Psychiatric Association (APA) to determine diagnoses. The DSM-5 provides standardized criteria for the classification of mental disorders, ensuring accurate and reliable diagnosis and treatment. Choices B and D are inaccurate as hospital policy does not dictate psychiatric diagnoses, and the American Medical Association is not responsible for psychiatric diagnostic criteria. Choice C describes a more general approach to assessment and does not specifically address the standardized criteria used in psychiatric diagnosis.
4. When assessing a patient with major depressive disorder, which symptom would most likely be observed?
- A. Euphoria
- B. Anhedonia
- C. Increased energy
- D. Racing thoughts
Correct answer: B
Rationale: Anhedonia, the inability to feel pleasure in activities that were once enjoyable, is a hallmark symptom of major depressive disorder. Patients with major depressive disorder often experience a pervasive feeling of emptiness and loss of interest in activities they used to find pleasurable. Euphoria, increased energy, and racing thoughts are more commonly associated with conditions like bipolar disorder rather than major depressive disorder.
5. A patient with schizophrenia is prescribed risperidone. The nurse should monitor the patient for which common side effect of this medication?
- A. Agranulocytosis
- B. Weight gain
- C. Hair loss
- D. Hyperthyroidism
Correct answer: B
Rationale: When a patient is prescribed risperidone, an atypical antipsychotic, the nurse should monitor for weight gain as it is a common side effect of this medication. Weight gain can occur due to metabolic changes and increased appetite associated with risperidone use. Agranulocytosis is a severe decrease in a type of white blood cells, and it is not a common side effect of risperidone. Hair loss and hyperthyroidism are also not typically associated with risperidone use.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access